logo
Loading...
Booster dose of BNT162b2 after two doses of CoronaVac improves neutralization of SARS-CoV-2 Omicron variant
Medicine and HealthCOMMUNICATIONS MEDICINE

Booster dose of BNT162b2 after two doses of CoronaVac improves neutralization of SARS-CoV-2 Omicron variant

G. R. F. Campos, N. B. F. Almeida, et al.

This groundbreaking study highlights the remarkable effect of a BNT162b2 mRNA vaccine booster dose on antibody neutralization against the SARS-CoV-2 Omicron variant. The research shows a dramatic increase in seroconversion rates from 10% to 76.6% after the booster, showcasing the enhanced immune response facilitated by this combined vaccination strategy. Conducted by a team of experts, this research offers significant insights into vaccine efficacy in combating emerging variants.... show more
GeneralSummaryMetrics
Introduction
Literature Review
Methodology
Key Findings
Discussion
Conclusion
Limitations
Related Publications

Explore these studies to deepen your understanding

Adjacent work that informs or extends this paper's methodology and findings.

Risk factors for and pregnancy outcomes after SARS-CoV-2 in pregnancy according to disease severity: A nationwide cohort study with validation of the SARS-CoV-2 diagnosis of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG)
Medicine and Health

Risk factors for and pregnancy outcomes after SARS-CoV-2 in pregnancy according to disease severity: A nationwide cohort study with validation of the SARS-CoV-2 diagnosis of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG)

A. J. M. Aabakke, T. G. Petersen, et al.

Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection
Medicine and Health

Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection

M. Patone, L. Handunnetthi, et al.

Cross-neutralization of Omicron BA.1 against BA.2 and BA.3 SARS-CoV-2
Medicine and Health

Cross-neutralization of Omicron BA.1 against BA.2 and BA.3 SARS-CoV-2

J. Zou, C. Kurhade, et al.

A bispecific nanobody dimer broadly neutralizes SARS-CoV-1 & 2 variants of concern and offers substantial protection against Omicron via low-dose intranasal administration
Medicine and Health

A bispecific nanobody dimer broadly neutralizes SARS-CoV-1 & 2 variants of concern and offers substantial protection against Omicron via low-dose intranasal administration

H. Ma, X. Zhang, et al.

Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 22+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny
    Booster dose of BNT162b2 after two doses of CoronaVac | ResearchBunny